United Nations Secretary-General Ban Ki-moon released a report today on the global AIDS epidemic outlining the progress against the pandemic to date and calling on all stakeholders to endorse the report’s recommendations and use them to work towards six global targets by 2015: Reduce by 50 percent the sexual transmission of HIV – including among key […]
Nelson L. Michael is a medical doctor, has a doctorate in molecular biology, holds the rank of colonel in the U.S. Medical Corps and his day job is huge: He is in charge of the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research in Rockville, Md. He oversees 750 people and his budget this year was $180 million.
But Michael is low-key to the core, and much of his job escapes public notice, even if he now is following multiple leads that resulted from a Thailand HIV vaccine study, which showed in 2009 for the first time that a preventive HIV vaccine was possible.
Often his job is figuring out how to make things work for research, and that has led him to Mozambique a couple of times in recent months to talk about starting a clinical trial site for HIV vaccine research…
The Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA) and the Center for Global Health Policy are calling for abstracts in the category of HIV/AIDS for presentation at the 49th Annual Meeting of IDSA, Oct. 20-23, 2011 in Boston. The Annual Meeting provides outstanding opportunities to have your research viewed by leaders in the field. IDSA, […]
Last week, the Center for Global Health Policy hosted three Fogarty International fellows in Washington, DC, and escorted them to the Hill to meet with key legislators with influence over global health programs and appropriations. Dr. Akao, a native Ugandan that has been practicing medicine since 2000 and now works at the Joint Clinical Research Center on integrated healthcare, describes the difference U.S. investment in the global AIDS epidemic has made in Uganda in this video clip.
Francis S. Collins, MD, PhD, is director of the National Institutes of Health (NIH). In that role he oversees the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research. Dr. Collins, a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of […]
Kevin M. DeCock, MD, is director of the Center for Global Health at the Centers for Disease Control and Prevention (CDC), based in Atlanta. Among his past positions are Director of CDC Kenya and Director of the World Health Organization’s Department of HIV/AIDS. John Donnelly talked with Dr. DeCock Thursday about the large numbers of […]
In a presentation to staffers from the U.S. Agency on International Development (USAID) and the World Health Organization last week, Dr. Liz Corbett presented on early diagnosis and prevention of tuberculosis and HIV in the community. A clinical researcher specializing in infectious diseases who has been based in Africa for more than a decade, Dr. […]
Quarraisha Abdool Karim, PhD, is an infectious diseases epidemiologist whose research involves understanding the evolving HIV epidemic in South Africa; factors influencing acquisition of HIV infection in adolescent girls; and sustainable strategies to introduce antiretroviral medicines in resource-constrained settings. She is an associate professor of Clinical Epidemiology at Columbia University’s Mailman School of Public Health […]
Kaitlin Christenson is coalition director for the Global Health Technologies Coalition (GHTC), an organization with more than three dozen member-groups that work on neglected diseases, including HIV/AIDS and tuberculosis. The coalition, formalized just two years ago, advocates for more research and backs new U.S. policies to accelerate the development of new drugs, vaccines, diagnostics, and […]
Dr. Nicholas Muraguri is head of Kenya’s National AIDS/STI Control Programme. He spoke with John Donnelly about the scope of the country’s male circumcision outreach plan (170,000 Kenyan males were circumcised last year), the lessons learned, and a problem he sees ahead: funding not keeping up with increased demand for treatment, spurred in part by the circumcision outreach program. This is the final post in a series of interviews on male circumcision (MC), which has been proven to protect a man by up to 60 percent from contracting HIV during vaginal sex.